<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 8, 1999
---------------
COMPARE GENERIKS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-27804 11-3289396
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
Formation)
60 Davids Drive, Hauppauge, New York 11788
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (800) 342-6555
-----------------------------
- --------------------------------------------------------------------------------
(Former name or former address, if changes since last report)
- --------------------------------------------------------------------------------
<PAGE>
Item 5. Other Events.
Compare Generiks, Inc. (the "Registrant") was advised by The Nasdaq
Stock Market that it did not comply with Marketplace Rule 4310(c)(04) because it
failed to meet the bid price requirements.
Accordingly, The Nasdaq Stock Market advised the Registrant that its
securities would be delisted effective on January 8, 1999. As a result, the
price of, and the volume of trading in, the Registrant's securities may be
negatively effected.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
(i) Letter from The Nasdaq Stock Market dated
January 12, 1999.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly authorized and caused the undersigned to sign this
Report on the Registrant's behalf.
COMPARE GENERIKS, INC.
By: /s/ Thomas Keith
-----------------------
Thomas Keith
Chief Financial Officer
Dated: January 15, 1999
<PAGE>
NASDAQ
The Nasdaq Stock Market, Inc.
1735 K Street, NW
Washington, DC 20006-1500
202 496 2500
Fax 202 496 2699
January 12, 1999
Mr. Thomas Keith
President and CEO
Compare Generiks, Inc.
300 Oser Avenue
Hauppauge, NY 11788
Dear Mr. Keith:
On January 8, 1999, your company's shares of common stock and warrants, which
traded under the symbol(s) COGE and COGEWI, were delisted from the Nasdaq
SmallCap Market. This action was taken as a result of your company's failure to
meet the bid price requirement(s) as stated in Marketplace Rule(s) 4310(c)(04).
If you have any questions, on this action or would like information on how to
reapply for inclusion of your security in The Nasdaq Stock Market, please fee
free to contact me at (202) 496-2569.
Very truly yours,
/s/ Kit Milholland
Kit Milholland
Associate Director
Nasdaq Listing Qualifications
- ----------
Nasdaq reserves the right to reassign, without prior notice, the trading symbol
previously utilized by the company while listed on The Nasdaq Stock Market.
Inclusion in the OTC Bulletin Board or similar service will not preclude
reassignment of the symbol, however, appropriate notifications will be provided
to respective market participants prior to reassignment.
